Dr. Joshua Russo joined Dr. Balk's laboratory in 2015. He is studying the
mechanisms of abiraterone resistance in castrate-resistant prostate cancer
(CRPC). Previously, he was a pathology resident at Beth Israel Deaconess
Medical Center. Prior to residency, he completed the M.D., Ph.D. program at
Tufts University School of Medicine with a Ph.D. research focus in the
Pathophysiology and Medical Management of Uterine Leiomyoma.
Email Dr. Russo
Publications (click underlined to go to publication):
and Castellot J. CCN5: biology and pathophysiology. J Cell Commun Signal. 2010;4(3):119-20.
Wiesman KC, Wei L, Baughman C, Russo J, Gray MR,
Castellot JJ. CCN5, a secreted protein, localizes to the nucleus . J Cell Commun Signal. 2010;4(2):91-98.
Wei L, McKeon F, Russo JW, Lemire J, Castellot J.
Domain and species specific monoclonal antibodies recognize the Von
Willebrand Factor-C domain of CCN5. J Cell Commun Signal.
Salem RO, Refaai MA, Cluette-Brown JE, Russo JW,
Laposata M. Fatty acid ethyl esters in liver and adipose tissues as
postmortem markers for ethanol intake. Clin Chem.
5. Ratto JA, Russo JW, Allen A, Herbert J, Wirsen C.
Biodegradable Polymers in the Marine Environment: A Tiered Approach to
Assessing Microbial Degradability. In: Gross R, Sholtz C, eds. Polymers
from Renewable Resources: Carbohydrates and Agro proteins, American
Chemical Society Symposium Series, Oxford Press, Dec 2000.